AssetMark Inc’s iShares Neuroscience and Healthcare ETF IBRN Stock Holding History

AssetMark Inc’s Portfolio IBRN Stock Details IBRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-100	Closed	-$3.88K	–	3830
2026 Q2	$3.88K	Buy	+100	New	+$3.51K	﹤0.01%	2766

AssetMark Inc's IBRN Position: Q3 2026 in Review

AssetMark Inc sold out of iShares Neuroscience and Healthcare ETF (IBRN) in Q3 2026, closing a stake of 100 shares — an estimated $3.88K sold.

AssetMark Inc first reported a position in IBRN in Q2 2026 and held it in 1 quarter. The position peaked at $3.88K in Q2 2026. 0 funds tracked by Wall St. Rank hold IBRN as of Q3 2026.

AssetMark Inc reported no remaining iShares Neuroscience and Healthcare ETF position as of Q3 2026 after selling out during the quarter.
AssetMark Inc sold 100 iShares Neuroscience and Healthcare ETF shares in Q3 2026, an estimated $3.88K.
AssetMark Inc first reported a position in iShares Neuroscience and Healthcare ETF in Q2 2026 and held it in 1 quarter.
AssetMark Inc's iShares Neuroscience and Healthcare ETF position peaked at $3.88K in Q2 2026.
0 funds tracked by Wall St. Rank held iShares Neuroscience and Healthcare ETF as of Q3 2026.

Based on AssetMark Inc's 13F filing for Q3 2026, filed 21 Oct 2026.